Lipid Emulsion, More Than Reversing Bupivacaine Cardiotoxicity: Potential Organ Protection
Efforts to develop a treatment for bupivacaine cardiotoxicity led to the discovery that Intralipid, a popular brand of intravenous lipid emulsion, could be used not only as an effective treatment for anesthetic-induced cardiac arrest, but also as a means of reversing many other toxicities. Contradic...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Canadian Society for Pharmaceutical Sciences
2018-01-01
|
Series: | Journal of Pharmacy & Pharmaceutical Sciences |
Online Access: | https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/29471 |
id |
doaj-d269805a893a4db09662777d60f988c8 |
---|---|
record_format |
Article |
spelling |
doaj-d269805a893a4db09662777d60f988c82020-11-25T03:10:37ZengCanadian Society for Pharmaceutical SciencesJournal of Pharmacy & Pharmaceutical Sciences1482-18262018-01-0120110.18433/J30D2VLipid Emulsion, More Than Reversing Bupivacaine Cardiotoxicity: Potential Organ ProtectionNegar Motayagheni0Sheshanna Phan1Ala Nozari2Anthony Atala3Institute for Regenerative Medicine, Wake Forest School of Medicine , Winston Salem, NC, USA.Division of Molecular Medicine, Department of Anesthesiology’ UCLA David Geffen School of Medicine, Los Angeles, CA, USA.Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.Efforts to develop a treatment for bupivacaine cardiotoxicity led to the discovery that Intralipid, a popular brand of intravenous lipid emulsion, could be used not only as an effective treatment for anesthetic-induced cardiac arrest, but also as a means of reversing many other toxicities. Contradictory data exist regarding the mechanism of action of lipid emulsion, a combination of fatty acids traditionally used in parenteral nutrition. Some researchers attribute the effects to lipophilicity and the individual characteristics of the lipids, while other data demonstrate a direct empowering mechanism through cellular upstream and downstream pathways. Understanding the underlying mechanism of action of this safe source of calories may assist in the development of novel organ protective agents. In this review, some of the direct cardiac effects of lipid emulsion are briefly discussed. This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page. https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/29471 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Negar Motayagheni Sheshanna Phan Ala Nozari Anthony Atala |
spellingShingle |
Negar Motayagheni Sheshanna Phan Ala Nozari Anthony Atala Lipid Emulsion, More Than Reversing Bupivacaine Cardiotoxicity: Potential Organ Protection Journal of Pharmacy & Pharmaceutical Sciences |
author_facet |
Negar Motayagheni Sheshanna Phan Ala Nozari Anthony Atala |
author_sort |
Negar Motayagheni |
title |
Lipid Emulsion, More Than Reversing Bupivacaine Cardiotoxicity: Potential Organ Protection |
title_short |
Lipid Emulsion, More Than Reversing Bupivacaine Cardiotoxicity: Potential Organ Protection |
title_full |
Lipid Emulsion, More Than Reversing Bupivacaine Cardiotoxicity: Potential Organ Protection |
title_fullStr |
Lipid Emulsion, More Than Reversing Bupivacaine Cardiotoxicity: Potential Organ Protection |
title_full_unstemmed |
Lipid Emulsion, More Than Reversing Bupivacaine Cardiotoxicity: Potential Organ Protection |
title_sort |
lipid emulsion, more than reversing bupivacaine cardiotoxicity: potential organ protection |
publisher |
Canadian Society for Pharmaceutical Sciences |
series |
Journal of Pharmacy & Pharmaceutical Sciences |
issn |
1482-1826 |
publishDate |
2018-01-01 |
description |
Efforts to develop a treatment for bupivacaine cardiotoxicity led to the discovery that Intralipid, a popular brand of intravenous lipid emulsion, could be used not only as an effective treatment for anesthetic-induced cardiac arrest, but also as a means of reversing many other toxicities. Contradictory data exist regarding the mechanism of action of lipid emulsion, a combination of fatty acids traditionally used in parenteral nutrition. Some researchers attribute the effects to lipophilicity and the individual characteristics of the lipids, while other data demonstrate a direct empowering mechanism through cellular upstream and downstream pathways. Understanding the underlying mechanism of action of this safe source of calories may assist in the development of novel organ protective agents. In this review, some of the direct cardiac effects of lipid emulsion are briefly discussed.
This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.
|
url |
https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/29471 |
work_keys_str_mv |
AT negarmotayagheni lipidemulsionmorethanreversingbupivacainecardiotoxicitypotentialorganprotection AT sheshannaphan lipidemulsionmorethanreversingbupivacainecardiotoxicitypotentialorganprotection AT alanozari lipidemulsionmorethanreversingbupivacainecardiotoxicitypotentialorganprotection AT anthonyatala lipidemulsionmorethanreversingbupivacainecardiotoxicitypotentialorganprotection |
_version_ |
1724658330183401472 |